Peptide Graded

BPC-157

Is BPC-157 safe?

No human safety data

CAnimal and cell studiesNot approvedas of 2026-10-27

Animal and lab safety studies reviewed in 2025 found no adverse effects across several organ systems in rodents. The peptide has a half-life under 30 minutes. The liver breaks it down and the kidneys clear it. The same review found no clinical safety data at all. 13

The practical risks are therefore those of an unregulated product. Vials sold online may have unknown purity, contamination or wrong labels. The FDA's 2023 decision placed BPC-157 in Category 2. It cited a lack of safety data and concerns about immune reactions and peptide impurities. The nominators later withdrew it, and the Category 2 page now lists it as nominated but withdrawn. BPC-157 promotes blood vessel growth in animal models. So there is a theoretical concern that it could feed tumours, but no study has examined this. WADA prohibits BPC-157 at all times under its non-approved substances class, and USADA has warned athletes about it. 7914

Read the full BPC-157 page

More on BPC-157

Citations

  1. International Journal of Molecular Sciences 2026: BPC 157 pentadecapeptide review doi.org
  2. Pharmaceuticals 2025: BPC 157 as a cytoprotective agent doi.org
  3. STAT News 2026: BPC-157 researcher Predrag Sikiric addresses skeptics statnews.com
  4. HSS Journal 2025: emerging use of BPC-157 in orthopaedic sports medicine, systematic review (DOI) doi.org
  5. ClinicalTrials.gov: NCT02637284 clinicaltrials.gov
  6. FDA: bulk drug substances used in compounding under section 503A fda.gov
  7. FDA: bulk drug substances that may present significant safety risks in compounding fda.gov
  8. STAT News 2026: FDA peptide compounding panel votes statnews.com
  9. USADA: BPC-157, a prohibited peptide usada.org
  10. Cell and Tissue Research 2019: BPC 157 cytoprotection review doi.org
  11. Staresinic 2003, J Orthop Res: BPC 157 accelerates healing of transected rat Achilles tendon pubmed.ncbi.nlm.nih.gov
  12. ClinicalTrials.gov registry clinicaltrials.gov
  13. HSS Journal 2025: emerging use of BPC-157 in orthopaedic sports medicine, systematic review pubmed.ncbi.nlm.nih.gov
  14. WADA: Prohibited List wada-ama.org

Reference information only, not medical advice. Drawn from the BPC-157 article, fact-checked against the cited sources. No dosing anywhere on this site.